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Abstract
Background: Current strategies for follow up of murine models of liver disease are flawed by inability to continuously
monitor disease progression in the tissue level, and necessitate sacrifice of animals for tissue sampling.
Aims: In this study we aimed at developing a safe repetitive tool for sampling livers in vivo, by utilization of a miniaturized
endoscopy system for laparoscopic liver biopsies and for injection of tumor cells into livers.
Results: We report the development of a protocol for murine laparoscopy that allows repeated visualization of murine intra-
abdominal organs. The system enables safe and repeated liver biopsies in mice and rats, yielding adequate tissue for
histological staining and RNA extraction. In addition, injection of tumor cells into livers facilitates under-vision implantation
of hepatic tumors in liver, followed by visualization of tumor growth.
Conclusions: Murine laparoscopy may be employed as a novel imaging modality for continuous assessment and
manipulation of chronic liver disease models.
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Introduction
Murine models are a major and frequently employed tool for
investigating mechanisms of liver disease. Multiple such models are
widely used for investigation of hepatic inflammation, steatosis,
fibrosis and tumorogenesis. The nearly universal course of such
experiments is sacrifice of animals at the end of the experiment and
assessment of the desired end points using histological and molecular
measures. This structure has several pitfalls. High mortality rates in
many models of acute and chronic liver disease necessitate large
numbers of mice in each experimental group. Inter-animal variability
makes the numbers needed to achieve meaningful and statistically
significant results even greater. Consecutive follow-up of disease
development and progression in individual mice is impossible,
resulting in utilization of surrogate parameters of disease activity
such as weight loss, loss of activity and mortality. While clinically
important, such parameters are difficult to predict and mechanisti-
cally assess relevant pathological and cellular processes.
In addition, in primary and metastatic liver tumor models,
implantation of tumor cells into original target organs, especially
deep within the abdominal cavity, can be technically challenging,
often necessitating tumor implantation in alternative, remote
locations, most often subcutaneously[1]. Such approaches disre-
gard the effect of the local milieu on tumor environment, thus
limiting the correlation between the model and naturally-
occurring tumors[2,3]. Liver tumors are fine examples of such
limitations, as intra-hepatic implantation of tumors in small
animals is achievable either by penetrative operational techniques
(associated with high mortality rates), or by intra-splenic injection
of tumor cells and hepatic metastasis which is associated with
unpredictable numbers of tumor cells arriving to the liver
parenchyma[4].
In this article, we describe a novel approach to combat these
technical limitations, using an easy to employ, safe and
reproducible murine laparoscopy technique. We suggest that
application of this approach may provide the investigator with the
tools to assess and manipulate disease progression in-vivo in
individual mice, allowing for a more comprehensive understand-
ing of mechanisms of disease progression.
Methods
Animals
Animals had unrestricted access to food and water, were housed
in temperature and humidity-controlled rooms, and were kept on
a 12-hour light/dark cycle. All animal studies were approved by
the Tel Aviv Sourasky Medical center ethical committee for
animal studies and conformed to the highest international
standards of humane care of animals in biomedical research.
Experimental procedures
8–10 week-old female C57BL/6 and Balb C mice and Wister
rats were obtained from Harlan biotech (Rehovot, Israel).
Methionine Choline Deficient diet (MCD Diet, MP Biomedicals,
Ohio, USA) was administered to C57BL/6 mice ad libitum for 8
weeks to induce NASH as described elsewhere[5]. Thioacetamide
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weekly intraperitoneal injection of 200 mg/kg Thioacetamide
(Sigma co., Rehovot, Israel)[6]. Green Fluorescent protein (GFP)
or Luciferase stably- transfected murine hepatic tumor cells
(BNL1ME) were kindly provided by Prof. Eithan Galun
(Hadassah-Hebrew University Medical Center).
Murine laparoscopic system
We employed a high resolution mouse video endoscopic system
(‘‘Coloview system’’) previously described for murine endoscopic
procedures[7], which consists of a miniature endoscope (scope
1.9 mm outer diameter), a xenon light source, a triple chip camera,
and an air pump to achieve regulated inflation of the mouse
peritoneal cavity (Karl Storz, Tuttlingen, Germany). The endo-
scopic procedure was viewed on a color monitor and digitally
recorded on tape. Biopsies were performed using a flexible biopsy
forceps with a diameter of 3 Fr. Intrahepatic injections were
accomplished using a 2 French catheter with a 25 G needle fitted at
its end, inserted through the working channel of the scope. Biopsies
were immediately placed in formaldehyde or liquid nitrogen.
Murine laparoscopic procedure
100 mcg/g Ampicillin and 5 mcg/g Gentamycin were subcu-
taneously administered to all mice peri-interventially, for a total
period of 2 days. Mice were anesthetized using Ketamine/
Xylazine. Aseptic technique was strictly followed. Skin incision
was made using scissors and scalpel, forming a minimal incision
two millimeters to the left (left lateral laparoscopy) or to the right
(right lateral laparoscopy) of the midline, at the epigastric region.
The incision was 1 mm in size, large enough to accommodate the
scope (approximately 1.5 mm). Air was insufflated through the
laparoscope into the peritoneal cavity to achieve adequate vision
of the abdominal cavity, and pneumoperitoneum was maintained
by the tight incision. By the end of the procedure, both operative
peritoneal and skin incisions were sutured using a single 3/0 silk
suture, respectively.
Histological examination
Hepatic biopsies and sections from excised liver were stained
with Hematoxylin and Eosin (all sections) and Sirius Red stain (in
fibrosis experiments). All sections were reviewed by an expert
blinded pathologist.
RNA extraction
Total cellular RNA from liver tissue was extracted with EZ-
RNA total RNA isolation kit (Biological Industries, Beit Haemek,
Israel) and transcribed into cDNA, using the Reverse Transcrip-
tion System (Sigma Aldrich, Rehovot, Israel). mRNA for albumin
and GADPH were obtained after 35 cycles of amplification
(annealing temperature of 56–62uC) using the following primers:
Albumin: Forward- CCTGATTGCCTTTTCCCAGTATC-
TCCAG, Reverse- CCAATGCTTTCTCCTTCACACCATCA,
GAPDH: Forward- AACTTTGGCATTGTGGAAGG, Reverse-
CACATTGGGGGTAGGAACAC.
Amplification products were visualized by ethidium bromide
after agarose electrophoresis and semiquantified by visually after
normalization against the GADPH internal control.
In vivo imaging
To follow luciferase-positive tumor implantation and growth,
the whole body cooled CCD camera system was used (IVISH 100
Series Imaging System, Xenogen, Alameda CA), as was previously
described[8]. For in-vivo visualization of GFP-positive tumors, the
Axioimager-M (Carl Zeiss, Oberkochen, Germany) fluorescent
microscopy system was used.
Results
Safety of procedures
Murine laparoscopy was performed in 150 mice. Laparoscopic
procedures were successfully performed in naı ¨ve mice as well as in
mice with TAA-fibrosis, MCD-deficient diet NASH, and liver
tumor models. After a short learning curve procedures could be
accomplished safely and reproducibly in all models. No periop-
erative mortality was noted in first-time biopsies, while repeat
procedures (performed in two week intervals) were associated with
a total 10% mortality rate, attributed to abdominal adhesions from
previous procedures, resulting in increase procedure time and
associated bleeding and anesthetic complications. No episodes of
infection were noticed in either first time or repeat procedures. We
now routinely perform 5 and more weekly repetitive laparoscopies
in diseased animals.
Visualization of abdominal organs by murine laparoscopy
As seen in figure 1 (right lateral laparoscopy), figure 2 (left
lateral laparoscopy) and video S1, high quality visualization of
internal abdominal organs could be easily achieved. Figure 3
depicts views obtained by right lateral laparoscopy of Wister rats
that yielded similar results. Visualized organs included the small
and large intestine, liver including the porta hepatis, gall bladder
and associated major vessels, spleen, pancreas, diaphragm (with
the beating heart and lungs visualized above it), urinary bladder,
and ovaries.
Laparoscopic macroscopic appearance of the liver in
health, NASH, and fibrosis
As is depicted in figure 3 and video S2, high resolution
imaging of the liver in health and in various disease states could be
achieved using murine laparoscopy. While healthy livers appear
violet in color and smooth in texture (figure 4A), severe steatosis
results in white discoloration (figure 4B), while fibrosis results in a
gray discoloration of the liver and intense granulation and
irregularities of its surface (figure 4C). In tumor models,
subscapular masses could be easily detected within days of
implantation (see below).
Laparoscopic biopsy-taking and histological examination
Liver biopsies were taken by a miniaturized biopsy forceps that
was inserted through the endoscope working channel. Biopsy
Figure 1. Right lateral laparoscopic imaging of mouse intra-
abdominal organs. A – Large intestine, B – Small intestine, C – Ovary,
D – heart and lungs viewed through diaphragm, E – urinary bladder.
doi:10.1371/journal.pone.0004776.g001
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endoscope to the desired liver segment, the other controlling the
opening and closure of the biopsy forceps. Multiple biopsies could
be undertaken, each lasting approximately 30 seconds. Mild, self-
contained bleeding validated that the liver tissue was indeed
biopsied (video S3). No mortality was associated with the biopsy.
Biopsy size was 3–7 mm in average. Time requirements for a
single laparoscopy for liver examination are around 45 seconds
per mouse. A biopsy prolongs the procedure by up to one extra
minute. Figure 5 depicts the histological staining of representative
biopsy specimens from normal liver (figure 5A, H&E stain),
MCD-induced non-alcoholic liver (figure 5B) showing an area of
intense lymphocytic exudate, figure 4C showing an area of severe
steatosis, (H&E stain) and a liver with TAA-induced fibrosis
(figure 5D, Sirius red stain). In all biopsy specimens, full
correlation was observed with corresponding histological slides of
livers from the same mice (data not shown).
Laparoscopic collection of hepatic mRNA
Biopsy specimens were also used for extraction of total liver
mRNA. In average, a single biopsy produced approximately 2
micrograms mRNA. This quantity of mRNA enabled the
assessment of multiple liver-specific or liver-non-specific gene
transcription products (such as albumin and GADPH, depicted in
figure 6).
Figure 2. Left lateral laparoscopic imaging of mouse intra-
abdominal organs. A – Spleen, B – Pancreas overhanging the spleen,
C – Bifurcation of the portal vein, D – Cystic duct and gallbladder.
doi:10.1371/journal.pone.0004776.g002
Figure 3. Laparoscopic imaging of rat intra-abdominal organs.
A- Liver, B-spleen and upper pole of left kidney, C- urinary bladder, D-
hepatic flexure of colon.
doi:10.1371/journal.pone.0004776.g003
Figure 4. Laparoscopic imaging of healthy and diseased livers.
A – Healthy liver, B – MCD Diet-induced NASH (with biopsy forceps in
frame), C – TAA-induced liver fibrosis.
doi:10.1371/journal.pone.0004776.g004
Figure 5. Histological sections from biopsies taken during
laparoscopy. A – normal liver (6100, H&E), B – TAA induced fibrosis
(6100, H&E), C - MCD Diet induced NASH (640, H&E), D - TAA induced
fibrosis (640, Serius Red).
doi:10.1371/journal.pone.0004776.g005
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One of the most attractive usages of murine laparoscopy is the
accurate guided implantation of tumor cells within target organs.
To demonstrate such ability, 56106 GFP or Fluorscin-positive
BNL1ME hepatocellular carcinoma cells were suspended in
200 microliter of HBSS and directly injected into the right hepatic
lobe through the murine laparoscope working channel (video S4).
Using the IVIS in-vivo imaging system for luminescence detection,
the fluorescin-positive tumor could be visualized within the liver as
soon as 3 days after implantation (data not shown), and was
brightly-positive in all luciferase-tumor harboring mice, but in non
of the sham-operated or GFP-positive mice, 10 days after tumor
implantation (figure 7A). Inversely, using the Carl Zeiss
Axioimager-M fluorescent microscopy system for in-vivo detection
of GFP signals, in the two mice in which a GFP-positive tumor was
implanted, intense fluorescent signal could be detected, while no
signal was omitted from either sham or fluorescin-positive tumors
(figure 7B). Liver excision from all mice confirmed that the GFP
signal, detected in-vivo, indeed originated from the hepatic tumors
(figure 7C). Tumors could be repetitively examined and biopsied
using routine weekly laparoscopy (figure 7d). In our hands,
tumor implantation by left lateral laparoscopy followed by
repeated visualization of tumor growth by right lateral thoracot-
omy yield the most reproducible results.
Discussion
We describe herein a novel approach for monitoring the
initiation and progression of liver disease in murine and other
small animal models, using a commercially available miniendo-
scopy system and a simple and safe laparoscopic technique. We
demonstrate that murine laparoscopy enables safe and repeated
visualization of a diverse variety of intra-abdominal organs.
Focusing on the liver, we show that our approach enables early
detection and follow up of macroscopic morphological changes in
several models of hepatic pathology and that laparoscopic liver
biopsies can reliably assess the pathological stage of disease, and
produce mRNA for molecular assessment of hepatic gene
expression. Moreover, we show that laparoscopy-guided local
injection of tumor cells into the liver results in in-situ development
of liver tumors. Most important, our approach enables repeated
visualization and intervention within the same mouse, such that
inter-animal variability can be avoided and detection of temporal
changes can be optimized.
Chronic liver disease and cirrhosis represent a common
worldwide health problem, affecting large and growing numbers
of the world population, causing a major burden on society’s
health expenditures. Common hepatic disorders, such as viral
hepatitis and non alcoholic steatohepatitis, are major risk factors
for the development of cirrhosis and hepatocellular carcinoma[9].
It has been well described in humans with liver disease that use of
laparoscopy as part of the evaluation of liver disease increases the
sensitivity of disease assessment[10,11].
Both MCD diet-induced and Thioacetamide-induced murine
liver disease models, employed in our study, are widely used for
investigation of human NASH and chronic liver fibrosis,
respectively. Although a MCD dietary model does not replicate
in full measure the pathogenesis of NASH in humans, it represents
one of the best-established methods to study the evolution of
inflammation, oxidant stress, and fibrotic changes associated with
NASH[12]. TAA induced liver fibrosis is considered a valid
model, simulating human cirrhotic histology and established portal
hypertension[13].
Figure 6. rtPCR from hepatic mRNA collected by laparoscopic
biopsy. In all four biopsied mice, albumin and GADPH mRNA
expression could be clearly detected.
doi:10.1371/journal.pone.0004776.g006
Figure 7. Liver tumors implanted during murine laparoscopy.
A. In-vivo imaging (IVIS 100) of hepatic luciferase signal in sham
operated, GFP-HCC implanted or luciferase-HCC implanted mice. B. In-
vivo imaging (ZIESS Axioimager-M) of hepatic GFP fluorescence in sham
operated, GFP-HCC implanted or luciferase-HCC implanted mice. C.
Repeated GFP imaging (ZIESS Axioimager-M) in excised livers of sham
operated, GFP-HCC implanted or luciferase-HCC implanted mice. D.
Laparoscopic appearance of liver-infiltrating GFP-HCC tumors 7 & 14
days following hepatic tumor cell implantation.
doi:10.1371/journal.pone.0004776.g007
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disease models may be particularly useful in states in which
mechanisms of disease progression are hard to elucidate in state of
high ‘background noise’ secondary to variations of disease severity
between individuals. Non alcoholic steatohepatitis is one fine
example, in which different stages of disease can be detected
within the same liver[14], and even more so between different
animals. Understanding of progression of simple steatosis to
steatohepatitis and chronic liver disease may be facilitated if livers
of the same animals be serially sampled for histological and
molecular markers, rather than relying on post mortem samples of
sibling animals that are frequently associated with significant inter-
animal variability.
Another advantage in such cases is the possibility of sampling at
early stages of disease, when pathological changes are mild to non-
existent, while continuing the follow up for subsequent disease
progression. In addition, tumor injection into predefined target
organs enables the incorporation of the important and often
disregarded aspect of the microenvironment local effects on tumor
growth and the tumor-environment crosstalk.
Limitations of the laparoscopic method include a certain (albeit
very low) rates of mortality of the procedure, mainly during the
learning curve phase of the procedure, and possible effects of
antibiotics and the sedation and trauma of the procedure on the
examined animal. Nevertheless, incorporation of murine laparos-
copy into the scope of in-vivo examinations enables the much
desired sensitive and repeatable online assessment of live small
animals, while dramatically reducing the need for large animal
groups for each experiment. In the near future, integration
between the laparoscopy approach and other in vivo imaging
modalities[15,16] may further enhance our ability for real-time
assessment of disease processes. In conclusion, murine laparoscopy
is a novel imaging modality that enables safe and effective
continuous assessment of chronic inflammatory, metabolic and
neoplastic liver disease models in mice.
Supporting Information
Video S1 Laproscopic examination of abdominal organs
Found at: doi:10.1371/journal.pone.0004776.s001 (2.12 MB
MPG)
Video S2 Laparoscopic macroscopic appearance of the liver in
health, NASH, and fibrosis
Found at: doi:10.1371/journal.pone.0004776.s002 (3.30 MB
MOV)
Video S3 Laparoscopic liver biopsy taking
Found at: doi:10.1371/journal.pone.0004776.s003 (0.84 MB
MOV)
Video S4 Laparoscopic local injection of tumor cells into the
liver
Found at: doi:10.1371/journal.pone.0004776.s004 (4.37 MB
MOV)
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